Chad vs Philippines: HIV/AIDS deaths averted by antiretroviral therapy
Chad
5,621 deaths
in 2024
Philippines
5,500 deaths
in 2024
Chad rank
33rd
Philippines rank
34th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Chad
- Philippines
How they compare
Chad currently reports 5,621 deaths against 5,500 deaths in Philippines, a difference of 121 deaths.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Philippines ahead.
Chad ranks 33rd and Philippines ranks 34th of 157 countries.
Chad has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Chad | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 925.64 deaths | 23.06 deaths | 902.59 deaths | Chad |
| 2010s | 3,844 deaths | 1,105 deaths | 2,740 deaths | Chad |
| 2020s | 5,000 deaths | 4,288 deaths | 711.9 deaths | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Chad or Philippines?
- Chad, at 5,621 deaths against 5,500 deaths in Philippines as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Chad and Philippines?
- 121 deaths, with Chad ahead.
- How many years of comparable data are there for Chad and Philippines?
- 35 years are reported by both, from 1990 to 2024.
- How do Chad and Philippines rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Chad ranks 33rd and Philippines ranks 34th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.